Publications by authors named "Elizabeth Ravenberg"

Claim this Profile
A
An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy.
Amanda L Rinkenbaugh, Yuan Qi, Shirong Cai, Jiansu Shao, Faiza Baameur Hancock, Elizabeth E Ravenberg

Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial.
Kevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, Stephanie L Graff, Kyong Hwa Park, Elizabeth Ravenberg

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An annotated biobank of triple negative breast cancer patient-derived xenografts featuring treatment-naïve and longitudinal samples throughout neoadjuvant chemotherapy.
Amanda L Rinkenbaugh, Yuan Qi, Shirong Cai, Jiansu Shao, Faiza Hancock, Elizabeth E Ravenberg

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.
Clinton Yam, Miral Patel, Holly A Hill, Ryan Sun, Roland L Bassett, Elizabeth E Ravenberg

Cancer Res Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer Subtypes.
Reva K Basho, Li Zhao, Jason B White, Lei Huo, Roland L Bassett, Elizabeth Ravenberg

JCO Precis Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens.
Hui Chen, Qingqing Ding, Laila Khazai, Li Zhao, Senthil Damodaran, Elizabeth Ravenberg

Ther Adv Med Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer.
Ken-Pin Hwang, Nabil A Elshafeey, Aikaterini Kotrotsou, Huiqin Chen, Jong Bum Son, Elizabeth E Ravenberg

Radiol Imaging Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy.
Nour Abuhadra, Ryan Sun, Roland L Bassett, Lei Huo, Jeffrey T Chang, Elizabeth E Ravenberg

Invest New Drugs· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer.
Clinton Yam, Elizabeth A Mittendorf, Haven R Garber, Ryan Sun, Senthil Damodaran, Elizabeth Ravenberg

Breast Cancer Res Treat· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial.
Nour Abuhadra, Ryan Sun, Clinton Yam, Gaiane M Rauch, Qingqing Ding, Elizabeth Ravenberg

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer.
Gloria V Echeverria, Shirong Cai, Yizheng Tu, Jiansu Shao, Emily Powell, Elizabeth E Ravenberg

NPJ Breast Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Ehsan Irajizad, Ranran Wu, Jody Vykoukal, Eunice Murage, Rachelle Spencer, Elizabeth Ravenberg

Front Artif Intell· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer.
Clinton Yam, Nour Abuhadra, Ryan Sun, Beatriz E Adrada, Qing-Qing Ding, Elizabeth E Ravenberg

Clin Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mid-treatment Ultrasound Descriptors as Qualitative Imaging Biomarkers of Pathologic Complete Response in Patients with Triple-Negative Breast Cancer.
Rosalind P Candelaria, Beatriz E Adrada, Deanna L Lane, Gaiane M Rauch, Stacy L Moulder, Elizabeth E Ravenberg

Ultrasound Med Biol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer.
Nour Abuhadra, Ryan Sun, Jennifer K Litton, Gaiane M Rauch, Clinton Yam, Elizabeth Ravenberg

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Rosalind P Candelaria, David A Spak, Gaiane M Rauch, Lei Huo, Roland L Bassett, Elizabeth E Ravenberg

Acad Radiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.
Clinton Yam, Er-Yen Yen, Jeffrey T Chang, Roland L Bassett, Gheath Alatrash, Elizabeth Ravenberg

Clin Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer.
Beatriz E Adrada, Rosalind Candelaria, Stacy Moulder, Alastair Thompson, Peng Wei, Elizabeth E Ravenberg

Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast Cancer.
Benjamin C Musall, Abeer H Abdelhafez, Beatriz E Adrada, Rosalind P Candelaria, Rania M M Mohamed, Elizabeth E Ravenberg

J Magn Reson Imaging· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer.
Clinton Yam, Gaiane M Rauch, Tanbin Rahman, Meghan Karuturi, Elizabeth Ravenberg

Invest New Drugs· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).
Abeer H Abdelhafez, Benjamin C Musall, Beatriz E Adrada, KennethR Hess, Jong Bum Son, Elizabeth E Ravenberg

Breast Cancer Res Treat· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients.
Rosalind P Candelaria, Beatriz E Adrada, Kenneth Hess, Lumarie Santiago, Deanna L Lane, Elizabeth E Ravenberg

Eur J Radiol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis